Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2887193 | Annals of Vascular Surgery | 2010 | 6 Pages |
Abstract
EVAR is safe in nonagenarians despite their advanced age and significant surgical risk factor profile. The procedure can be performed with excellent technical success and a low rate of perioperative complications. However, mortality rates after 30 days are significant. The substantial long-term mortality raises the question of possible treatment futility in this unique population. While age should not be a contraindication for EVAR, recommendations for the procedure should be based on individual patient selection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeffrey Jim, Luis A. Sanchez, Gregorio A. Sicard, John A. Curci, Eric T. Choi, Patrick J. Geraghty, M. Wayne Flye, Brian G. Rubin,